Avalo Therapeutics (AVTX) Assets (2014 - 2026)
Avalo Therapeutics (AVTX) posted Assets of $490.78 million for Q2 2026, up 287.7% from $126.58 million a year earlier and up 391.3% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Avalo Therapeutics' Assets came in at $116.46 million, down 22.7% from FY2024.
- Annual Assets shows a five-year compound annual growth rate of 21.6% (FY2020 to FY2025).
- In prior years, Avalo Therapeutics' Assets was $150.73 million in FY2024 (+618.0%), $20.99 million in FY2023 (-37.1%), $33.37 million in FY2022 (-58.4%) and $80.21 million in FY2021 (+83.3%).
- The Q2 2026 figure stands as the highest quarterly Assets in data going back to Q4 2014.
- On a year-over-year basis, Assets increased in six of the last eight quarters, with growth averaging 143.4%.
- The strongest year-over-year quarter for Assets in the past five years was Q4 2024, with growth of 618.0%; the weakest was Q3 2022, with a decline of 61.7%.
- According to Business Quant data, Assets for the three prior quarters was $99.89 million (Q1 2026), $116.46 million (Q4 2025) and $125.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Avalo Therapeutics | 657.52 Mn | 657.52 Mn | - | 490.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 490.78 Mn |
| Mar 31, 2026 | 99.89 Mn |
| Dec 31, 2025 | 116.46 Mn |
| Sep 30, 2025 | 125.10 Mn |
| Jun 30, 2025 | 126.58 Mn |
| Mar 31, 2025 | 138.52 Mn |
| Dec 31, 2024 | 150.73 Mn |
| Sep 30, 2024 | 98.46 Mn |
| Jun 30, 2024 | 108.31 Mn |
| Mar 31, 2024 | 123.73 Mn |
| Dec 31, 2023 | 20.99 Mn |
| Sep 30, 2023 | 29.27 Mn |
| Jun 30, 2023 | 24.24 Mn |
| Mar 31, 2023 | 36.24 Mn |
| Dec 31, 2022 | 33.37 Mn |
| Sep 30, 2022 | 36.55 Mn |
| Jun 30, 2022 | 32.22 Mn |
| Mar 31, 2022 | 61.90 Mn |
| Dec 31, 2021 | 80.21 Mn |
| Sep 30, 2021 | 95.36 Mn |
API Access
Avalo Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();